Bertha A. Hidalgo
University of Alabama at Birmingham
Also published as: Bertha Hidalgo
9 papersORCID 0000-0002-2556-1969OpenAlex
University of Alabama at Birmingham
- Chronic kidney disease
- Type 2 diabetes
- Coronary artery disease
- DNA methylation
- Epigenetic regulation of gene expression
- Body mass index
- Polygenic risk score
- Clonal hematopoiesis of indeterminate potential
Is this you? Claim this profile
Papers
Kidney Medicine
Incident Type 2 Diabetes in Individuals With CKD: The REGARDS Study
Cohort study of 7,511 peopleChronic kidney disease
Clinical Journal of the American Society of Nephrology
Integrated Risk Prediction of Kidney Failure: Clinical and Multi-Omic Approaches
Cohort study in peopleKidney failure
Nature Communications
An integrated germline and somatic genomic model for coronary artery disease
Cohort study of 391,536 peopleCoronary artery disease
ENDO 2025 Abstract
MON-561 Epigenetic Age Acceleration in African American Adolescents with Type 2 Diabetes
Cross-sectional study in peopleType 2 diabetes
Western Journal of Nursing Research
Neighborhood Environment and Epigenetic Age: A Scoping Review
Systematic review of observational studiesPopulations
Science Advances
Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential
Mendelian randomization in 63,302 peopleTelomerase and telomere maintenance
Clinical Epigenetics
Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN study
Study in peopleBiomarkers
Works at
University of Alabama at Birmingham
Associate professor
Sources: reporter.nih.gov
Grants and prizes
National Heart, Lung, and Blood Institute
K01, Epigenomics of Cardiometabolic Diseases in Mexican Americans, K01HL130609, 2016–2021, Jun 22, 2019
Sources: reporter.nih.gov